- Markets
- Healthcare
- FERMENTA
FERMENTA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Manali Petrochemicals Signs Pact With Fermenta Biotech
Dec 18 (Reuters) - Manali Petrochemicals Ltd MNLI.NS:
EXECUTES MOU WITH FERMENTA BIOTECH
CONSIDERATION FOR LEASE RIGHTS FOR PREMISE AT 187 MILLION RUPEES
Source text: ID:nNSE8DXG1C
Further company coverage: MNLI.NS
(([email protected];))
Dec 18 (Reuters) - Manali Petrochemicals Ltd MNLI.NS:
EXECUTES MOU WITH FERMENTA BIOTECH
CONSIDERATION FOR LEASE RIGHTS FOR PREMISE AT 187 MILLION RUPEES
Source text: ID:nNSE8DXG1C
Further company coverage: MNLI.NS
(([email protected];))
Fermenta Biotech To Sell Its Commercial Office Premises At Worli, Mumbai
Dec 17 (Reuters) - Fermenta Biotech Ltd FERM.BO:
TO SELL ITS COMMERCIAL OFFICE PREMISES AT WORLI, MUMBAI
DEAL FOR 400 MILLION RUPEES
Source text: ID:nBSE1T33Mn
Further company coverage: FERM.BO
(([email protected];;))
Dec 17 (Reuters) - Fermenta Biotech Ltd FERM.BO:
TO SELL ITS COMMERCIAL OFFICE PREMISES AT WORLI, MUMBAI
DEAL FOR 400 MILLION RUPEES
Source text: ID:nBSE1T33Mn
Further company coverage: FERM.BO
(([email protected];;))
Fermenta Biotech Executes MoU To Sell Commercial Office Premises At Mumbai
Oct 16 (Reuters) - Fermenta Biotech Ltd FERM.BO:
EXECUTED MOU TO SELL COMMERCIAL OFFICE PREMISES AT MUMBAI
DEAL FOR 400 MILLION RUPEES
Source text for Eikon: ID:nBSE6BkzwT
Further company coverage: FERM.BO
(([email protected];;))
Oct 16 (Reuters) - Fermenta Biotech Ltd FERM.BO:
EXECUTED MOU TO SELL COMMERCIAL OFFICE PREMISES AT MUMBAI
DEAL FOR 400 MILLION RUPEES
Source text for Eikon: ID:nBSE6BkzwT
Further company coverage: FERM.BO
(([email protected];;))
Fermenta Biotech Receives EU GMP Certification For Its Dahej Manufacturing Facility
Sept 23 (Reuters) - Fermenta Biotech Ltd FERM.BO:
RECEIVES EU GMP CERTIFICATION FOR ITS DAHEJ MANUFACTURING FACILITY
Source text for Eikon: ID:nBSE79n0Jc
Further company coverage: FERM.BO
(([email protected];;))
Sept 23 (Reuters) - Fermenta Biotech Ltd FERM.BO:
RECEIVES EU GMP CERTIFICATION FOR ITS DAHEJ MANUFACTURING FACILITY
Source text for Eikon: ID:nBSE79n0Jc
Further company coverage: FERM.BO
(([email protected];;))
Fermenta Biotech Receives EU GMP Compliance Certificate For Manufacturing Facility In Gujarat
Sept 19 (Reuters) - Fermenta Biotech Ltd FERM.BO:
RECEIVES EU GMP COMPLIANCE CERTIFICATE FOR MANUFACTURING FACILITY IN GUJARAT
Source text for Eikon: ID:nBSE9mtPpG
Further company coverage: FERM.BO
(([email protected];;))
Sept 19 (Reuters) - Fermenta Biotech Ltd FERM.BO:
RECEIVES EU GMP COMPLIANCE CERTIFICATE FOR MANUFACTURING FACILITY IN GUJARAT
Source text for Eikon: ID:nBSE9mtPpG
Further company coverage: FERM.BO
(([email protected];;))
Fermenta Biotech Executes Sale Deed To Sell Substantial Portion Of Land Situated At Village Takve Budruk
Dec 4 (Reuters) - Fermenta Biotech Ltd FERM.BO:
EXECUTED SALE DEED TO SELL SUBSTANTIAL PORTION OF LAND SITUATED AT VILLAGE TAKVE BUDRUK
DEAL FOR 448.3 MILLION RUPEES
Source text for Eikon: ID:nBSE8DgC4P
Further company coverage: FERM.BO
(([email protected];))
Dec 4 (Reuters) - Fermenta Biotech Ltd FERM.BO:
EXECUTED SALE DEED TO SELL SUBSTANTIAL PORTION OF LAND SITUATED AT VILLAGE TAKVE BUDRUK
DEAL FOR 448.3 MILLION RUPEES
Source text for Eikon: ID:nBSE8DgC4P
Further company coverage: FERM.BO
(([email protected];))
Fermenta Biotech Says Co's Factory At Kullu, Himachal Pradesh Restored To Normalcy Since August 11, 2023
Aug 11 (Reuters) - Fermenta Biotech Ltd FERM.BO:
CO'S FACTORY AT KULLU, HIMACHAL PRADESH RESTORED TO NORMALCY SINCE AUGUST 11, 2023
Source text for Eikon: ID:nBSE6r3xY8
Further company coverage: FERM.BO
(([email protected];;))
Aug 11 (Reuters) - Fermenta Biotech Ltd FERM.BO:
CO'S FACTORY AT KULLU, HIMACHAL PRADESH RESTORED TO NORMALCY SINCE AUGUST 11, 2023
Source text for Eikon: ID:nBSE6r3xY8
Further company coverage: FERM.BO
(([email protected];;))
Fermenta Biotech Says Operations At Kullu Factory Have Partially Resumed Since July 21
July 21 (Reuters) - Fermenta Biotech Ltd FERM.BO:
OPERATIONS AT KULLU FACTORY HAVE PARTIALLY RESUMED SINCE JULY 21
Source text for Eikon: ID:nBSEwwn8d
Further company coverage: FERM.BO
(([email protected];))
July 21 (Reuters) - Fermenta Biotech Ltd FERM.BO:
OPERATIONS AT KULLU FACTORY HAVE PARTIALLY RESUMED SINCE JULY 21
Source text for Eikon: ID:nBSEwwn8d
Further company coverage: FERM.BO
(([email protected];))
Fermenta Biotech Says In View Of Heavy Rainfall In Himachal Pradesh, Operations At Co's Facility In Kullu Stopped Completely Since July 10
July 11 (Reuters) - Fermenta Biotech Ltd FERM.BO:
IN VIEW OF HEAVY RAINFALL IN HIMACHAL PRADESH OPERATIONS AT CO'S FACILITY IN HIMACHAL PRADESH STOPPED COMPLETELY SINCE JULY 10
WILL REPORT DETAILS TO RESTORE ITS OPERATIONS, DAMAGE CAUSED, INSURANCE AMOUNT REALIZED AND COMMENCEMENT OF OPERATIONS AT KULLU FACTORY
Source text for Eikon: ID:nBSEb54L4b
Further company coverage: FERM.BO
(([email protected];))
July 11 (Reuters) - Fermenta Biotech Ltd FERM.BO:
IN VIEW OF HEAVY RAINFALL IN HIMACHAL PRADESH OPERATIONS AT CO'S FACILITY IN HIMACHAL PRADESH STOPPED COMPLETELY SINCE JULY 10
WILL REPORT DETAILS TO RESTORE ITS OPERATIONS, DAMAGE CAUSED, INSURANCE AMOUNT REALIZED AND COMMENCEMENT OF OPERATIONS AT KULLU FACTORY
Source text for Eikon: ID:nBSEb54L4b
Further company coverage: FERM.BO
(([email protected];))
India's Fermenta Biotech Posts March-Qtr Consol Loss vs Profit
May 29 (Reuters) - Fermenta Biotech Ltd FERM.BO:
INDIA'S FERMENTA BIOTECH LTD MARCH-QUARTER CONSOL LOSS AFTER TAX 37.5 MILLION RUPEES VERSUS PROFIT 76.8 MILLION RUPEES
FERMENTA BIOTECH LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.05 BILLION RUPEES VERSUS 961.6 MILLION RUPEES
FERMENTA BIOTECH LTD - FINAL DIVIDEND 1.25 RUPEES PER SHARE
Source text for Eikon: ID:nBSE4qCMKS
Further company coverage: FERM.BO
(([email protected];))
May 29 (Reuters) - Fermenta Biotech Ltd FERM.BO:
INDIA'S FERMENTA BIOTECH LTD MARCH-QUARTER CONSOL LOSS AFTER TAX 37.5 MILLION RUPEES VERSUS PROFIT 76.8 MILLION RUPEES
FERMENTA BIOTECH LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.05 BILLION RUPEES VERSUS 961.6 MILLION RUPEES
FERMENTA BIOTECH LTD - FINAL DIVIDEND 1.25 RUPEES PER SHARE
Source text for Eikon: ID:nBSE4qCMKS
Further company coverage: FERM.BO
(([email protected];))
Upcoming Events:
e-Voting
Events:
Dividend
Dividend
Dividend
Dividend
Bonus
Dividend
Dividend
Dividend
Bonus
Split
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Fermenta Biotech do?
DIL Ltd offers research support services, manufactures enzymes and chemicals, provides entertainment, and develops levitation technology and wheelchairs. They excel in tailored solutions for efficient drug discovery, also involved in property, treasury & other activities.
Who are the competitors of Fermenta Biotech?
Fermenta Biotech major competitors are Advanced Enzyme, Concord Biotech, Biocon, Anuh Pharma, Kwality Pharma, Wanbury, Shivalik Rasayan. Market Cap of Fermenta Biotech is ₹857 Crs. While the median market cap of its peers are ₹957 Crs.
Is Fermenta Biotech financially stable compared to its competitors?
Fermenta Biotech seems to be less financially stable compared to its competitors. Altman Z score of Fermenta Biotech is 3.27 and is ranked 7 out of its 8 competitors.
Does Fermenta Biotech pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Fermenta Biotech latest dividend payout ratio is 23.34% and 3yr average dividend payout ratio is 23.34%
How has Fermenta Biotech allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Accounts Receivable, Short Term Loans & Advances
How strong is Fermenta Biotech balance sheet?
Balance sheet of Fermenta Biotech is strong. But short term working capital might become an issue for this company.
Is the profitablity of Fermenta Biotech improving?
Yes, profit is increasing. The profit of Fermenta Biotech is ₹35.93 Crs for TTM, -₹23.06 Crs for Mar 2024 and -₹51.08 Crs for Mar 2023.
Is the debt of Fermenta Biotech increasing or decreasing?
Yes, The debt of Fermenta Biotech is increasing. Latest debt of Fermenta Biotech is ₹81.83 Crs as of Sep-24. This is greater than Mar-24 when it was ₹12.69 Crs.
Is Fermenta Biotech stock expensive?
Fermenta Biotech is not expensive. Latest PE of Fermenta Biotech is 24.12, while 3 year average PE is 35.99. Also latest EV/EBITDA of Fermenta Biotech is 12.0 while 3yr average is 27.56.
Has the share price of Fermenta Biotech grown faster than its competition?
Fermenta Biotech has given better returns compared to its competitors. Fermenta Biotech has grown at ~70.44% over the last 1yrs while peers have grown at a median rate of 6.58%
Is the promoter bullish about Fermenta Biotech?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 64.09% and last quarter promoter holding is 62.06%.
Are mutual funds buying/selling Fermenta Biotech?
There is Insufficient data to gauge this.